|11 April 2017||Mortality improvements in the next decade Discussion led by the CMI Mortality Projections Committee at a SIAS meeting. An audio recording is available on the SIAS website.|
|28 October 2016||Proposed "08" Series Accelerated Critical Illness and Term Mortality tables Presented by the CMI Assurances Committee at a discussion forum|
|29 June and 11 July 2016||Consultation on the CMI Mortality Projections Model. Presentation at consultation meetings by the CMI Mortality Projections Committee. [These slides are from the London meeting on 11 June. They contain some changes compared to the Edinburgh meeting on 29 June; they also contain some revised figures reflecting revisions made in the July 2016 version of Working Paper 90.]|
|19 November 2015||
Steve Bale and Mark Cooper gave a presentation on High Age Mortality at the 2015 Life Conference
|15 and 26 October 2015||The Future of the CMI Mortality Projections Model (pdf). Presentation at consultation meetings by the CMI Mortality Projections Committee. [These slides are from the London meeting on 26 October. They contain minor changes compared to the Edinburgh meeting on 15 October.]|
|29 January 2015||CMI Update (pdf). Presentation by Tim Gordon and Dave Grimshaw at the IFoA Mortality and Longevity Seminar|
|24 November 2014||Graduation of annuity data, 2007-2010 (pdf). Presented by the CMI Annuities Committee at a discussion forum|
|10 November 2014||Do we need to update the 00 series tables? CMI Assurances results for 2007-2010. Presentation by James Tait and Jamie Leitch at the Life Conference 2014|
|15 September 2014||Innovations in the CMI’s approach to graduation and modelling. Presentation by Tim Gordon and Jon Palin at the Mortality and Longevity Symposium 2014.|
|3 June 2014||Projecting future mortality trends. Presentation by the CMI Mortality Projections Committee: Staple Inn Actuarial Society (SIAS).|
|23 May 2014||A critical update - CMI CI results. Presentation by James Tait and Jamie Leitch at the Health and Care Conference 2014.|
|16 May 2013||Insights into Recent Income Protection Experience by Cause of Sickness. Presentation by Duncan Heald and Hannah Cook at the Health and Care Conference 2013.|
|15 May 2013||Critical Illness Claims Experience. Presentation on the CMI critical illness investigation by James Tait and Jamie Leitch at the Health and Care Conference 2013.|
|15 May 2013||CMI Update. A overview by Gordon Sharp of the CMI’s recent work, presented to the Bristol Actuarial Society.|
|8 February 2013||CMI SAPS Update. Presentation on the latest results from the CMI SAPS investigation, by Deborah Cooper. ACA members' conference 2013|
|12 June 2012||CMI Update. Presentation on CMI mortality-related activity given by Gordon Sharp at the Mortality and Longevity Seminar in London.|
|16 May 2012||CMI Life Office Data Submissions. Short presentation on the CMI's plans for data collection from the life office mortality and the critical illness investigations; given by Dave Grimshaw at Current issues in Life Assurance, 2012.|
|1 May 2012||CMI Income Protection Investigation Update.Presentation giving an overview of trends in IP experience over the period 1975-2009 and summarising the investigation methodology and the features of the latest graduations, IPM 1991-98; given by Joan Coverson and Neil Robjohns at the Health and Care Conference 2012.|
|3 February 2012||The CMI Mortality Projections Model. Gordon Sharp presented an overview of the CMI mortality projections model, its evolution and current use to the ACA members' conference 2012.|
|6 December 2011||The Continuous Mortality Investigation (1924-2011 and on). Gordon Sharp presented an overview of the CMI’s work and future plans to the Bristol Actuarial Society.|
|6 October 2011||CMI SAPS Mortality Update. Presentation on recent progress in the SAPS Mortality investigation and the Committee’s planned future work, by Deborah Cooper. Current Issues in Pensions 2011.|
|2 June 2011||Mortality in 2011 and Beyond - An Update from the CMI SAPS Committee. Presentation on recent progress in the SAPS Mortality investigation and the Committee’s planned future work, by Deborah Cooper. Pensions Conference 2011.|
|20 May 2011||Critical Illness Insurance: AC04 Diagnosis Rates. Presentation on Working paper 50 and subsequent progress in the CMI Critical illness investigation, by David Heeney and Dave Grimshaw. Health and care conference 2011.|
|December 2010 / January 2011||The Latest CMI Model and Discussion of Current Practice. Open forum on the CMI mortality projections model, presented by Gordon Sharp and Neil Robjohns (London, 9 December 2010; Edinburgh, 19 January 2011).|
|8 November 2010||Critical Illness - Learning from Experience. Presentation on recent progress in the CMI Critical illness investigation, by David Heeney and Dave Grimshaw. Life conference 2010.|
|14 May 2010||Critical Illness - Learning from Experience. Presentation on recent progress in the CMI Critical illness investigation, by David Heeney and Dave Grimshaw. Health and care conference 2010.|
|March 2010||Update on the Latest Work of the CMI. Seminar presentation on CMI mortality-related activity, including a review of issues commonly raised on implementation of the CMI Mortality projections model, given by Neil Robjohns. Mortality and longevity seminars (London, 17 March; Leeds, 25 March).|
|8 December 2009||Launch of the New CMI Mortality Projections Model. Webinar presentation, by Gordon Sharp, Richard Willets and Neil Robjohns.|
|16 November 2009||The SAPS Mortality Investigation: The CMI Mortality Projections Model. Presentation by Gordon Sharp and Richard Willets. Current issues in pensions seminars (Manchester, 6 November; London, 16 November).|
|28 October 2009||An Update from the CMI on IP and CI. Presentation on recent progress in the CMI Critical illness and Income protection investigations, by Neil Robjohns. Current issues in health and care seminar 2009.|
|5 October 2009||CMI Mortality Projections Model. Presentation by Richard Willets. Current issues in life assurance II seminar 2009.|
|7 July 2009||CMI Mortality Projections Model. Presentation at the consultation meetings, by Gordon Sharp, Neil Robjohns and Richard Willets. (Edinburgh, 7 July; London, 14 July).|
|4 June 2009||Current Issues in Mortality. Presentation by Gordon Sharp to the Glasgow Actuarial Students' Society (GASS).|
|March/April 2009||CMI Update. Presentation on recent CMI work on mortality, by Neil Robjohns and Brian Wilson. Mortality and longevity seminars (Manchester 23 March; London, 1 April).|
|16 May 2008||CMI Critical Illness Investigation. Presentation on recent progress in the CMI Critical illness investigation, by David Heeney and Dave Grimshaw. Healthcare conference 2008.|
|28 January 2008||EU Gender Directive: A CMI Perspective. Presentation on the publication of data in response to the EU gender directive, by Dave Grimshaw. ILAG Health and protection briefing.|
|12 December 2007||CMI Critical Illness Investigation. Presentation on recent progress in the CMI Critical illness investigation, by David Heeney and Dave Grimshaw. Current issues in healthcare seminar 2007.|
|July 2007||CMI Library of Mortality Projections. Presentation to the consultation meetings, by Gordon Sharp and Dave Grimshaw. (Edinburgh, 18 July; London 20 & 26 July).|
|7 June 2007||Mortality - Where Are We and Where We're Going. Presentation by Dave Grimshaw. Pensions convention 2007.|
|May 2007||Mortality Projections. Presentation by Dave Grimshaw. Current issues in life assurance seminar 2007.|
|9-11 May 2007||CMI Critical Illness investigation. Learning from Experience. Presentation by David Heeney and Hamish Wilson. Healthcare conference 2007.|
|26 April 2007||CMI Mortality Investigations. Presentation by Dave Grimshaw. Mortality and longevity seminars 2007.|
|26 April 2007||CMI SAPS Investigation. Presentation by Brian Wilson. Mortality and longevity seminars 2007.|
|6 December 2006||CMI Critical Illness Investigation. Presentation by Dave Grimshaw. Critical illness - MOT or cosmetic surgery? seminar 2006.|
|22 September 2006||Current Mortality Issues. Presentation by Angus Macdonald to the Groupe Consultatif colloquium in Edinburgh.|
|May 2006||IP Trends by Cause of Disability. Presentation by David Leach. Healthcare conference 2006.|
|7 December 2005||CMI Critical Illness Update. Presentation by Dave Grimshaw. Current issues in critical illness seminar 2005.|
|28 September 2005||Update on the 00 Series. Presentation by Tony Leandro. Current issues in life assurance seminar 2005.|
|28 September 2005||Annuity Values. Presentation at the Current issues in life assurance seminar, 2005. The annuity values presented by the CMI at CILA were calculated using improvement factors derived from projections carried out using the P-Spline models. The P-Spline parameters used by the CMI for this purpose and a brief description of how the annuity values were calculated from the P-Spline projections is given in the attached note. Please note that the parameters set out in this note are provided only to provide information to replicate the annuity values presented. These parameters are not recommended by the CMI.|
|September 2005||Mortality Projections Associated with the '00' Series Tables. Presentation at workshops on new projection methodologies and software (London, 12 September; Edinburgh, 14 September).|
|23-24 September 2004||Workshop on Lee-Carter Methods Presentation at an invitation-only workshop on projecting future mortality, held as part of the Mortality Projections Working Party's ongoing research into this area. The CMI is very grateful to Iain Currie for organising this event.|
If you have any questions about the CMI please email
Filter or search events
CILA is one of the pre-eminent events in the annual 'Life' calendar. Due to COVID-19 we are running the programme as a series of webinars covering topics aimed at practicing life actuaries from life offices, consulting firms and other employers of actuaries and those who work in or advise on, the life assurance market in the UK and Europe.
Current Issues in Life Assurance – Mortality in 2020 is now dominated by one thing, although – in our future-focused world – the pandemic is just one of many mortality considerations. In this session, three well-regarded mortality/longevity specialists provide an overview of implications and impacts of COVID-19, recent and imminent CMI developments and more 'future focused' work in the MRSC
Because of Covid-19, forecasters predict a severe recession in 2020, followed by a V or U-shaped recovery. This impacts both individuals and companies. However, compared to previous recessions, the impact on banks of higher credit losses should be mitigated to some extent by government actions.
Part of the Protection, Health and Care Conference 2020 webinar series
This session will provide an overview of the Population Health Management Working Party's research including defining impactability and impactability modelling, discussing some examples of specific modelling approaches, considering the practical challenges across the NHS as well as wider public perception and ethical issues.
Many actuaries consider career opportunities in the Finance and Investment practice area after having started off in more traditional actuarial roles such as valuations, capital management or pricing. This session is aimed at helping actuaries to better understand roles in Finance and Investment and how they can fine tune their skills to pursue such careers.
Due to COVID-19, we are running this programme via a series of webinars commencing 22nd July.
This webinar series will provide topical and practical updates and discussion on the latest thinking and innovations in mortality and longevity, and is designed to be very accessible to a broad range of experience.
Insurers are making increasing use of medical research to help with assumption, models and underwriting. Experienced mortality/ longevity specialists discuss the issues in the interpretation of medical research papers, using a range of case studies. The case studies will include COVID-19 points of current importance. Many of the concepts discussed (data bias, inference of causation) are also applicable to equivalent questions in 'big data' and advanced analytics.
Members of the Mortality Working Group of the IAA have analysed changes in mortality for about 30 causes of death and will discuss how causes of death are classified, and the problems of long-term data, appropriate metrics, including "years of life lost" (YLL), causes of death - a "measure of cohortness", the changes in dominant causes of death at older ages, and how can these types of studies enhance mortality forecasting.
Predictive risk assessment and risk stratification models based on postcode-level consumer classification are widely used for life insurance underwriting. However, these are socio-economic models not directly related to health information. Similar to precision medicine, precision life insurance should aim to tailor policy pricing/reserving to the individual health characteristics of each client.
The aim of this webinar is to provide an overview of research undertaken within the Data Science Working Party on applying machine learning methods for sentiment analysis and opinion mining of UK Twitter data relating to COVID-19.
This discussion, the fourth in the Extreme Mortality Events webinar series, will look at what poor model selection and calibration could look like – using inappropriate historical data; using incorrect 2020 mortality data; and inappropriate stochastic model recalibration (or lack thereof). Presented by Chair of the Life Board of the Institute and Faculty of Actuaries, Colin Dutkiewicz.
This webinar has been re-scheduled from its original date of the 1st July. Although ESG has many buyers across the asset allocation community, from pension funds to sovereign wealth funds, it still hasn’t found its place within the core asset management strategy desks where the money is actually invested. The problem as well as the opportunity is Fixed Income. Plenty of strategies exist for incorporating ESG within Equities, from screening, integration to a combination. ESG has picked up relatively quickly within Equities with rating,indices created using ESG factors. This talk will discuss how we price a quantifiable ESG credit risk premium and make it alpha worthy in a strategy.
Over the past decades, many countries have exhibited mortality rates approximately following a piecewise linear law. This is visible in the form of steady improvements over multiple years, followed by a rather abrupt trend change, and then again stable improvements according to the new trend.
Part of the Protection, Health and Care Conference 2020 webinar series
With the rising prevalence of dementia, how can we manage this risk effectively and can insurance do more? Matt Singleton, Ageing Lead at Swiss Re, will cover these topics and demonstrate how insurance could help people address their concerns.
Current Issues in Life Assurance – Join us for an exploration session on the use of data science in insurance companies today including how insurers are making sense of and using new data sources and technologies, exploration of practical applications of data science within actuarial work, benefits of data-driven decisions to solve business problems using the power of data and technology, and the role that actuaries can play to harness the benefits of data science.
Current Issues in Life Assurance
This talk will look at a range of such techniques (e.g. mass lapse risk transfer, contract boundaries, risk margin relief, non-standard longevity risk transfer) that have been applied or considered by UK and EU insurers, and the pros and cons of each.
Current Issues in Life Assurance.
The International Association of Insurance Supervisors announced on 14 November 2019 the adoption of v2.0 of the global Insurance Capital Standard (ICS) which will undergo confidential reporting for 5 years starting from 2020. This session will include specific experiences from Legal and General (L&G) as well as global industry perspectives from EY.
Current Issues in Life Assurance
This session will cover the PRA supervisory statement on financial impacts related to climate change, industry insights into PRA climate risk business plans, examples climate risk strategy setting out key workstreams and activity steps for successful execution, an overview of a climate risk strategy execution timeline and the future.
On 25 June the International Accounting Standards Board published Amendments to IFRS 17, the Insurance Contracts global accounting standard effective 1 January 2023.
Part of the Protection, Health and Care Conference 2020 webinar series
This session will cover how we have challenged conventional approaches to underwriting and risk selection in order to develop an approach that aligns current practices, customer and broader interests with robust risk assessment.
Part of the Protection, Health and Care Conference 2020 webinar series. Using new and unique research and data from the UK, US, Sweden and China, this presentation investigates how consumers use the internet through their insurance journey and analyzes the role culture and generation plays in their online behaviour. We use this research to show the online landscape for insurance sales in the UK and suggest ways to shape new products and effectively engage with the consumer who is buying them.
Chief Medical Officer (CMO) for Gen Re Life/Health Research and Development, Dr John O'Brien, will discuss the impacts of Gene Modification for life/health insurance.
Our presentation will examine the challenges arising in setting mortality improvement assumptions, exposing known but under-explored vulnerabilities of current practices.
As an industry, it has been important to be able to look to the future to identify the next quantifiable risk. In this session, I will explore some of the less tangible, but none-the-less concerning risks to future health, such as the health risks associated with exposure to pesticides, ingestion of plastic in the food chain, and the hazards of indoor air pollution through exposure to volatile organic compounds.
The working party will help the industry to update and enhance how potential risk from diabetes and excess mortality is considered, including the need to understand the underwriting implications as treatments improve, and potentially to develop new products that are tailored to those with diabetes.
This event is now fully booked. To join the wait list, please register here.
A Trusted Profession
Part of the Protection, Health and Care Conference 2020 webinar series. Modelling the structure and trends of cancer morbidity risk is important for pricing and reserving in related health insurance fields such as critical illness insurance and care provision. We model the dynamics of cancer incidence over time in different regions in England, using 1981-2016 ONS data. The modelling allows estimation of cancer rates at various age, year, gender and region levels, following a Bayesian setting to account for statistical uncertainty. Our analysis indicates significant regional variation in cancer incidence rates.
Part of the Protection, Health and Care Conference 2020 webinar series. In this talk we will outline the steps Aviva took in pulling together our first large-scale disclosures on the exposure of our business to climate change published in March 2019; in line with the recommendations of the Taskforce on Climate-related Financial Disclosures. After touching on why insurers have such an important role in climate change, we'll cover a brief “how-to” guide for those who have not yet embarked on thinking about these topics before giving a case study of how the learnings from a TCFD disclosure exercise can be applied to investment portfolios.
Part of the Protection, Health and Care Conference 2020 webinar series.
The insurance industry currently underwrites customers with diabetes based on a range of factors, medical expertise and various medical studies. The work undertaken by the Diabetes Working Party would help the industry to approach this using current research findings to update and enhance how potential risk from diabetes is considered. This includes the need to understand the underwriting implications as treatments improve, and potentially to develop new products that are tailored to those with diabetes. This webinar will present our latest findings in the management of this important chronic condition which will include research in collaboration with the ARC.